Literature DB >> 3965714

Drug glycosides: potential prodrugs for colon-specific drug delivery.

D R Friend, G W Chang.   

Abstract

The influence of prodrug structure on specificity of glycoside/glycosidase based colon-specific drug delivery was studied by preparing nine steroid glycosides, measuring their relative lipophilicities, and hydrolyzing them with bacterial glycosidases from rat intestines. The 21-yl beta-D-glucosides and galactosides of dexamethasone, prednisolone, hydrocortisone, and fludrocortisone and the 21-yl beta-D-cellobioside of prednisolone were prepared by a modified Koenigs-Knorr reaction. The deacetylated glycoside prodrugs, along with the P-nitrophenyl derivatives of beta-D-glucoside, galactoside, and cellobioside, were subjected to hydrolysis by the contents of the rat stomach, proximal small intestine (PSI), distal small intestine (DSI), and cecum. All the prodrugs were hydrolyzed slowly by PSI and stomach contents, more rapidly by contents of the DSI, and most rapidly by cecal contents. This is the basis of the site-specific drug delivery reported earlier (Friend, D. R.; Chang, G. W. J. Med. Chem. 1984, 27, 261). Furthermore, the prodrugs themselves had very different susceptibilities to hydrolysis. Hydrolysis rates catalyzed by DSI contents decreased in the following order: prednisolon-21-yl beta-D-galactoside (10) greater than prednisolon-21-yl beta-D-glucoside (2) greater than prednisolon-21-yl beta-D-cellobioside (13) greater than dexamethason-21-yl beta-D-galactoside (9) greater than dexamethason-21-yl beta-D-glucoside (1). Hydrolysis of cellobioside 13 was only half that of glucoside 2 and one-fourth that of galactoside 10. Hydrolysis of all the prodrugs in cecal contents was rapid, with the exceptions of hydrocortison-21-yl beta-D-glucoside (5) and fludrocortison-21-yl beta-D-glucoside (7), which were hydrolyzed more slowly than the other glucoside prodrugs. Eadie-Hofstee plots for hydrolysis of the glucoside compounds suggested that bacterial beta-D-glucosidase activity in the colon may be more heterogeneous in nature than beta-D-galactosidase activity. Relative lipophilicities of the prodrugs and free steroids were compared by measuring their octanol-buffer partition coefficients (P). The logarithm of the P of cellobioside 13 (-0.56) was considerably lower than that of the other prodrugs, which ranged from 0.11 to 0.84. Log P of the free steroids ranged from 1.54 to 1.73. These relative rates of hydrolysis and relative lipophilicities, along with previously reported animal experiments, enable one to estimate the site specificity of glycoside prodrugs prior to extensive animal studies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965714     DOI: 10.1021/jm00379a012

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

Review 1.  Colonic drug delivery: prodrug approach.

Authors:  V R Sinha; R Kumria
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

2.  Colon targeted drug delivery systems: a review on primary and novel approaches.

Authors:  Anil K Philip; Betty Philip
Journal:  Oman Med J       Date:  2010-04

Review 3.  Colon-targeted oral drug delivery systems: design trends and approaches.

Authors:  Seth Amidon; Jack E Brown; Vivek S Dave
Journal:  AAPS PharmSciTech       Date:  2015-06-13       Impact factor: 3.246

4.  In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery.

Authors:  B Haeberlin; W Rubas; H W Nolen; D R Friend
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

5.  Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine.

Authors:  Inho Kim; Hyesik Kong; Younghyun Lee; Sungchae Hong; Jungoh Han; Sunhwa Jung; Yunjin Jung; Young Mi Kim
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

6.  Menthol-beta-D-glucuronide: a potential prodrug for treatment of the irritable bowel syndrome.

Authors:  H W Nolen; D R Friend
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

7.  The relation between swelling properties and enzymatic degradation of azo polymers designed for colon-specific drug delivery.

Authors:  G Van den Mooter; C Samyn; R Kinget
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

8.  In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier.

Authors:  A Rubinstein; R Radai; M Ezra; S Pathak; J S Rokem
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

9.  Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig.

Authors:  T N Tozer; J Rigod; A D McLeod; R Gungon; M K Hoag; D R Friend
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

10.  In vivo evaluation of a colon-specific drug delivery system: an absorption study of theophylline from capsules coated with azo polymers in rats.

Authors:  G Van den Mooter; C Samyn; R Kinget
Journal:  Pharm Res       Date:  1995-02       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.